C9ORF46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.288600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.405400E-01
Normal-vs-Stage2
4.052000E-01
Normal-vs-Stage3
4.945800E-01
Normal-vs-Stage4
7.236800E-01
Stage1-vs-Stage2
9.735200E-01
Stage1-vs-Stage3
8.560400E-01
Stage1-vs-Stage4
2.712600E-01
Stage2-vs-Stage3
7.630200E-01
Stage2-vs-Stage4
2.066800E-01
Stage3-vs-Stage4
3.424600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.442800E-01
Normal-vs-AfricanAmerican
1.681350E-01
Normal-vs-Asian
2.157000E-01
Caucasian-vs-AfricanAmerican
7.453400E-01
Caucasian-vs-Asian
4.353600E-01
AfricanAmerican-vs-Asian
7.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.026000E-01
Normal-vs-Female
4.540000E-01
Male-vs-Female
5.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.198210E-01
Normal-vs-Age(41-60Yrs)
3.187200E-01
Normal-vs-Age(61-80Yrs)
4.732600E-01
Normal-vs-Age(81-100Yrs)
6.915000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.910200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.145000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.571600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.265200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.557600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.703000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.082000E-01
Normal-vs-Daily Drinker
7.670300E-02
Normal-vs-Weekly Drinker
8.743600E-01
Normal-vs-Occasional Drinker
3.765600E-01
Normal-vs-Social Drinker
7.783800E-01
Non Drinker-vs-Daily Drinker
1.616790E-01
Non Drinker-vs-Weekly Drinker
3.305200E-01
Non Drinker-vs-Occasional Drinker
9.582000E-01
Non Drinker-vs-Social Drinker
4.853400E-01
Daily Drinker-vs-Weekly Drinker
8.724200E-02
Daily Drinker-vs-Occasional Drinker
2.052400E-01
Daily Drinker-vs-Social Drinker
1.328030E-01
Weekly Drinker-vs-Occasional Drinker
3.634000E-01
Weekly Drinker-vs-Social Drinker
8.384000E-01
Occasional Drinker-vs-Social Drinker
5.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.432800E-01
Normal-vs-Grade 2
8.005600E-01
Normal-vs-Grade 3
8.341600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.349800E-02
Grade 1-vs-Grade 3
2.910000E-02
Grade 1-vs-Grade 4
7.432800E-01
Grade 2-vs-Grade 3
3.214200E-01
Grade 2-vs-Grade 4
8.005600E-01
Grade 3-vs-Grade 4
8.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.883800E-01
Normal-vs-NonDiabetic
3.777000E-01
Diabetic-vs-NonDiabetic
9.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.422000E-02
Normal-vs-NoPancreatitis
4.206000E-01
Pancreatitis-vs-NoPancreatitis
3.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.014400E-01
Normal-vs-N1
4.295200E-01
N0-vs-N1
7.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.359400E-01
Normal-vs-TP53-NonMutant
4.268400E-01
TP53-Mutant-vs-TP53-NonMutant
5.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
